NIST and NCI to collaborate on proteomics assessment

The National Institute of Standards and Technology (NIST) and the National Cancer Institute (NCI) of the National Institutes of Health have begun a program to develop measurement assessment materials needed to evaluate and assess advanced proteomic technologies, such as mass spectrometry, that will play a large role in the discovery and validation of cancer-related proteins found in readily accessible body fluids.

The discovery that the appearance of specific proteins (or changes in the structure or concentration of a protein) in body fluids could be associated with the presence of particular cancers goes back to the 19th century, but actually identifying and validating these proteins has been difficult. Humans are estimated to have roughly 400,000 different proteins, with the specifics constantly changing with age, health and environment. In the 159 years since the discovery of the first protein cancer biomarker, only nine proteins have been approved by the Food and Drug Administration as diagnostic markers for cancer.

The rapidly developing field of proteomics--the large-scale study of proteins and their interactions through methods such as multidimensional separations, mass spectrometry and protein arrays--could significantly advance the search for novel cancer-related proteins. However, there is a shortage of rigorous measurement quality assurance tools for proteomics to ensure reliable and reproducible research results. NCI has begun a $104 million, 5-year program called the Clinical Proteomic Technology Initiative for Cancer (http://proteomics.cancer.gov) to refine and standardize proteomic technologies, reagents and methods to establish the measurement technology needed to validate protein discoveries and move these technologies into a clinical setting.

Under an agreement finalized on May 5, NIST will develop a measurement assessment material composed of proteins mimicking the complexity an

Contact: Michael Baum
National Institute of Standards and Technology (NIST)

Page: 1 2

Related biology news :

1. K-State to collaborate on research to forecast ecological consequences of environmental changes
2. UT Metroplex institutions to collaborate on biomedical research
3. Pacific Rim researchers to collaborate on distributed bioinformatics analysis of avian flu
4. Universities collaborate to look at offshore wind power
5. University and health science center in San Antonio collaborate to find chlamydia vaccine
6. Worcester Polytechnic Institute, CellThera collaborate on work aimed at regenerating limbs
7. ORNL, protein discovery researchers collaborate on high-profile paper
8. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
9. Universities collaborate to to reduce development impact on the James River
10. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
11. Roche and SystemsX collaborate in diabetes research

Post Your Comments:

(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
(Date:6/23/2020)... ... 23, 2020 , ... First Aid Africa, a Scottish charity ... and manufacturer of innovative portable renewable energy equipment, have announced the success of ... COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable solar power ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku Corporation ... next event in a series of TOPIQ webinars, which will cover the Transferable ... was developed in response to social distancing measures that resulted in postponements and ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , ... announced the placement of Julianne Averill , CPA, as Chief Financial Officer ... operations and implementing key business strategies to accelerate Alveo’s growth as the company ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , ... of its Scientific Advisory Board (SAB) to research the medical potential of terpenes and ... enhanced when combined with terpenes. The board is focused on expanding the recently launched ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society ... Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of ... a consortium of academic research centers in the United States and Europe with ...
(Date:8/12/2020)... , ... August 12, 2020 , ... ... (EMMA International), a global leader in FDA compliance consulting has been named ... fastest-growing private companies. The list represents a unique look at the most successful ...
Breaking Biology Technology:
Cached News: